Literature DB >> 21427645

Depression and atherosclerosis.

V G Saleptsis1, N Labropoulos, A Halaris, N V Angelopoulos, A D Giannoukas.   

Abstract

The aim of this paper was to examine the interaction between depression and atherosclerosis through a systematic review. A Medline search was performed from 1966 through 2009 using relevant terms such as depression, epidemiology and atherosclerosis. This was supplemented by a thorough manual search using bibliographies of reviews and full articles. The papers were divided and analyzed separately for each vascular bed. Depression is diagnosed usually before atherosclerosis becomes obvious. The contribution of depression in the development of atherosclerosis emerges from various mechanisms, including lack of physical activity, that exist in this illness. Controversies about the etiology and pathogenesis exist. These interactions of all elements and the importance of each one have not been investigated adequately. Repeated objective measurements for atherosclerosis are lacking. There is an association between depression and atherosclerosis, but the strength of this relationship has to be determined. Prospective studies are needed to determine the early and long term effects of their interaction.

Entities:  

Mesh:

Year:  2011        PMID: 21427645

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

1.  Focal points of preanesthesia evaluations for electroconvulsive therapy in patients with depression: a retrospective analysis of clinical characteristics in nonremission.

Authors:  Lei Zou; Xiao Li; Qibin Chen; Feng Lv; Su Min
Journal:  BMC Anesthesiol       Date:  2022-05-26       Impact factor: 2.376

Review 2.  Inflammation, heart disease, and depression.

Authors:  Angelos Halaris
Journal:  Curr Psychiatry Rep       Date:  2013-10       Impact factor: 5.285

Review 3.  Behavioral impairments in animal models for zinc deficiency.

Authors:  Simone Hagmeyer; Jasmin Carmen Haderspeck; Andreas Martin Grabrucker
Journal:  Front Behav Neurosci       Date:  2015-01-06       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.